← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2016Last known activity
Feb 29, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06262776Lead sponsorN/AFeb 29, 2024
- NCT06262776Sponsor investigatorN/AFeb 29, 2024
- NCT04453852Overall official - principal investigatorPhase 1Jun 30, 2020
- NCT04453852CollaboratorPhase 1Jun 30, 2020
- NCT03066986Reponsible party - principal investigatorPhase 1/Phase 2Oct 1, 2016
- NCT03066986Lead sponsorPhase 1/Phase 2Oct 1, 2016
Details
- Last known activity
- Feb 29, 2024